They're the best-selling joint ingredients in the world, and for once nobody had to guess: the NIH ran the largest trial ever attempted on them — 1,583 people, five arms, a real placebo — and then followed a subset of them for two years. The answer is more useful than the label copy, and less flattering.
Knees have a way of announcing their age. Stairs get louder. The first steps out of bed take negotiating. And the supplement aisle has had the same answer ready for thirty years: glucosamine and chondroitin, usually sold together, taken by millions of Americans. If any joint ingredient should have airtight evidence by now, it’s this pair. So it’s worth knowing that the biggest, cleanest test ever run on them was funded by the NIH precisely to settle the question — and what it found.
First, the theory. Glucosamine and chondroitin are natural components of cartilage — the smooth tissue that cushions the ends of your bones. The pitch is intuitive: aching joints involve worn cartilage, so swallow the building blocks. Intuitive, though, is not the same as demonstrated, and cartilage doesn’t simply absorb whatever the bloodstream carries past it. That’s what trials are for.
In 2006, the New England Journal of Medicine published the Glucosamine/Chondroitin Arthritis Intervention Trial — GAIT — an NIH-funded study of 1,583 people with painful knee osteoarthritis. Participants were randomly assigned to glucosamine, chondroitin, both together, the prescription anti-inflammatory celecoxib, or placebo for 24 weeks.[1] Five arms, blinded, at sixteen centers — about as rigorous as supplement research gets.
The results: 60.1% of the placebo group reported meaningful pain relief. Glucosamine came in at 64.0%, chondroitin at 65.4%, and the combination at 66.6% — none of them statistically better than the sugar pill.[1] The trial itself wasn’t broken: celecoxib, the prescription comparator, did separate from placebo (70.1%), which means the study was capable of detecting a real effect. It just didn’t find one for the supplements.
There was one intriguing wrinkle. Among the smaller subgroup who started with moderate-to-severe pain, the combination beat placebo — 79.2% versus 54.3%.[1] The authors themselves flagged this as exploratory: a smaller sample, and the kind of result that generates a hypothesis rather than proving one. The confirmation never came. In a two-year continuation of GAIT — a 662-person subset of the original trial, so a smaller and less powerful test — no arm, whether glucosamine, chondroitin, the combination, or celecoxib, achieved a clinically important difference from placebo on pain or function.[2]
In the largest U.S. trial ever run — 1,583 people, NIH-funded, placebo-controlled — glucosamine and chondroitin, alone or together, were not significantly better than placebo for knee-osteoarthritis pain overall at 24 weeks, nor in a smaller two-year continuation.[1][2] An exploratory subgroup signal in people with worse baseline pain was never confirmed. Summarized from peer-reviewed studies. This is general information, not medical advice.
Partly because earlier, mostly European trials of a particular glucosamine sulfate product reported better results — and many of those were funded by the manufacturer. When researchers at Bern pooled ten large trials in a 2010 network meta-analysis in the BMJ, they concluded the effect of glucosamine, chondroitin, or the combination on joint pain was, in their words, clinically irrelevant compared with placebo.[3] The NIH’s center for complementary medicine sums the field up as uncertain at best.[4] And in their 2019 guideline, the American College of Rheumatology and the Arthritis Foundation went further: they strongly recommend against glucosamine for knee, hip, and hand osteoarthritis — one of the few supplements singled out that directly.[5] In fairness, the orthopedic surgeons’ guideline (AAOS, 2021) is gentler — it lists glucosamine and chondroitin among supplements that “may be helpful” for mild-to-moderate knee osteoarthritis — but it grades its own evidence for that as limited and inconsistent, which is a long way from an endorsement.[6]
The other reason is more human: people who take it often do feel better. Look back at that placebo number — 60% reported real relief. Osteoarthritis pain waxes and wanes on its own, and the act of doing something about it carries genuine, measurable comfort. That’s not a trick; it’s just not something you need to buy a particular bottle to get.
The trial wasn’t broken — the prescription drug beat placebo. The supplements didn’t. Both facts came from the same study.
The good news: in GAIT, side effects were mild and roughly even across every group, placebo included.[1] Three practical cautions. Most glucosamine is made from shellfish shells, so a shellfish allergy is a conversation to have with your pharmacist first. Glucosamine may raise blood sugar in some people, which matters if you have diabetes or are watching your glucose.[4] And glucosamine-chondroitin products have been associated with an increased risk of bleeding in people taking the blood thinner warfarin — if you take one, that conversation isn’t optional.[4]
If glucosamine and chondroitin were a new ingredient today, the GAIT results would have ended the story. They persist on momentum, marketing, and the very real comfort of the placebo response. If you take the pair and feel it helps, it’s inexpensive and appears safe for most people — that’s a defensible personal call, best made with your doctor in the loop. But if you’re deciding where to spend effort on aching knees, the evidence points somewhere less glamorous and much better proven: movement, muscle, and weight — the subject of our review of what actually holds up.
General information, not medical advice. Supplements are not intended to diagnose, treat, cure, or prevent any disease. Talk to your doctor or pharmacist before starting one, especially alongside medication.